Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)

Creative Medical Technology Holdings: $4.5 million warrant exercise at $1.60 per share

Mixed Impact 3 of 5 financing Written later

On June 30, 2026, Creative Medical Technology Holdings agreed with warrant holders to exercise existing warrants for 2,790,340 shares at a reduced price of $1.60 per share, down from $2.86, for gross proceeds of about $4.5 million before advisory fees. In exchange, the company issued new warrants for 5,580,680 shares at $1.60, which cannot be exercised until stockholder approval is obtained, so the transaction adds both cash and potential future share issuance for shareholders.

Key points

  • Existing warrants for 2,790,340 shares were exercised at $1.60 per share, reduced from $2.86, for about $4.5 million in gross proceeds before advisory fees.
  • New Inducement Warrants cover 5,580,680 shares at $1.60 and are exercisable for five years after Nasdaq-required stockholder approval.
  • Roth Capital Partners, LLC receives a fee of 8% of gross proceeds plus $50,000 in reimbursed legal expenses.
  • On July 1, 2026, the Compensation Committee approved a $100,000 bonus for CEO Timothy Warbington.

The filing

CompanyCREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
Form8-K, current report
Filed with the SECJul 2, 2026, 4:15 PM ET
Accession number0001477932-26-004165

Items reported: 1.01 Material Definitive Agreement3.02 Unregistered Equity Sale5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 02, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.